De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–... von Nitz, Ulrike, Gluz, Oleg, Graeser, Monika, Christgen, Matthias, Kuemmel, Sherko, Grischke, Eva-Maria, Braun, Michael, Augustin, Doris, Potenberg, Jochem, Krauss, Katja, Schumacher, Claudia, Forstbauer, Helmut, Reimer, Toralf, Stefek, Andrea, Fischer, Hans Holger, Pelz, Enrico, zu Eulenburg, Christine, Kates, Ronald, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Harbeck, Nadia, von Schumann, Raquel, Kuhn, Walther, Polata, Silke, Bielecki, Wojciech, Meyer, Ralf, Just, Marianne, Kraudelt, Susanne, Siggelkow, Wulf, Wortelmann, Heidi, Kleine-Tebbe, Anke, Leitzen, Lena, Kirchhof, Heidrun, Krabisch, Petra, Hackmann, John, Depenbusch, Reinhard, Gnauert, Karsten, Staib, Peter, Lehnert, Antje, Hoffmann, Oliver, Briest, Susanne, Lindner, Christoph, Heyl, Volker, Bauer, Leila, Uleer, Christoph, Mohrmann, Svjetlana, Viehstaedt, Nicole, Malter, Wolfram, Link, Theresa, Buendgen, Nana, Tio, Joke

Volltext

Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12‐week neoadjuvant therapy for different early breast cancer subtypes: Combined analysi... von Graeser, Monika, Schrading, Simone, Gluz, Oleg, Strobel, Kevin, Würstlein, Rachel, Kümmel, Sherko, Schumacher, Claudia, Grischke, Eva‐Maria, Forstbauer, Helmut, Braun, Michael, Christgen, Matthias, Adams, Jascha, Nitzsche, Henrik, Just, Marianne, Fischer, Hans Holger, Aktas, Bahriye, Potenberg, Jochem, Schumann, Raquel, Kolberg‐Liedtke, Cornelia, Harbeck, Nadia, Kuhl, Christiane K., Nitz, Ulrike

Volltext

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer von Harbeck, Nadia, von Schumann, Raquel, Kates, Ronald Ernest, Braun, Michael, Kuemmel, Sherko, Schumacher, Claudia, Potenberg, Jochem, Malter, Wolfram, Augustin, Doris, Aktas, Bahriye, Forstbauer, Helmut, Tio, Joke, Grischke, Eva-Maria, Biehl, Claudia, Liedtke, Cornelia, De Haas, Sanne Lysbet, Deurloo, Regula, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Gluz, Oleg

Volltext

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials von Graeser, Monika, Schrading, Simone, Gluz, Oleg, Strobel, Kevin, Herzog, Christopher, Umutlu, Lale, Frydrychowicz, Alex, Rjosk-Dendorfer, Dorothea, Würstlein, Rachel, Culemann, Ralph, Eulenburg, Christine, Adams, Jascha, Nitzsche, Henrik, Prange, Anna, Kümmel, Sherko, Grischke, Eva-Maria, Forstbauer, Helmut, Braun, Michael, Potenberg, Jochem, von Schumann, Raquel, Aktas, Bahriye, Kolberg-Liedtke, Cornelia, Harbeck, Nadia, Kuhl, Christiane K, Nitz, Ulrike

Volltext

The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials von Graeser, Monika, Harbeck, Nadia, Gluz, Oleg, Würstlein, Rachel, zu Eulenburg, Christine, Schumacher, Claudia, Grischke, Eva-Maria, Forstbauer, Helmut, Dimpfl, Moritz, Braun, Michael, Christgen, Matthias, Kreipe, Hans Heinrich, Potenberg, Jochem, von Schumann, Raquel, Aktas, Bahriye, Kolberg-Liedtke, Cornelia, Kümmel, Sherko, Nitz, Ulrike

Volltext

Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients von Wuerstlein, Rachel, Harbeck, Nadia, Grischke, Eva-Maria, Forstmeyer, Dirk, von Schumann, Raquel, Krabisch, Petra, Lüdtke-Heckenkamp, Kerstin, Stefek, Andrea, Stoetzer, Oliver, Grafe, Andrea, Kaltenecker, Gabriele, Forstbauer, Helmut, Augustin, Doris, Schrader, Iris, Tio, Joke, Nitz, Ulrike, Gluz, Oleg, Kates, Ronald E., Graeser, Monika Karla

Volltext

De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker... von Harbeck, Nadia, Gluz, Oleg, Christgen, Matthias, Kates, Ronald Ernest, Braun, Michael, Küemmel, Sherko, Schumacher, Claudia, Potenberg, Jochem, Kraemer, Stefan, Kleine-Tebbe, Anke, Augustin, Doris, Aktas, Bahriye, Forstbauer, Helmut, Tio, Joke, von Schumann, Raquel, Liedtke, Cornelia, Grischke, Eva-Maria, Schumacher, Johannes, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Nitz, Ulrike Anneliese

Volltext

Abstract P2-16-05: Efficacy of response- and toxicity-guided neoadjuvant chemotherapy in elderly early breast cancer patients: Results of WSG ADAPT elderly sub-trial von Kuemmel, Sherko, Gluz, Oleg, Christgen, Matthias, Potenberg, Jochem, Hackmann, John, von Schumann, Raquel, Graeser, Monika, Mangold, Marina, Wuerstlein, Rachel, Kates, Ronald, Kreipe, Hans H., Nitz, Ulrike, Harbeck, Nadia

Volltext

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the... von Harbeck, Nadia, Nitz, Ulrike A, Christgen, Matthias, Kümmel, Sherko, Braun, Michael, Schumacher, Claudia, Potenberg, Jochem, Tio, Joke, Aktas, Bahriye, Forstbauer, Helmut, Grischke, Eva-Maria, Scheffen, Iris, Malter, Wolfram, von Schumann, Raquel, Just, Marianne, Zu Eulenburg, Christine, Biehl, Claudia, Kolberg-Liedtke, Cornelia, Deurloo, Regula, de Haas, Sanne, Jóźwiak, Katarzyna, Hauptmann, Michael, Kates, Ronald, Graeser, Monika, Wuerstlein, Rachel, Kreipe, Hans H, Gluz, Oleg

Volltext

De-escalated chemotherapy versus endocrine therapy plus pertuzumab+ trastuzumab for HR+/HER2+ early breast cancer (BC): First efficacy results from the neoadjuvant WSG-TP-II study von Gluz, Oleg, Nitz, Ulrike, Christgen, Matthias, Kuemmel, Sherko, Holtschmidt, Johannes, Priel, Jan, Hartkopf, Andreas, Potenberg, Jochem, Luedtke-Heckenkamp, Kerstin, Just, Marianne, Wuelfing, Pia, von Schumann, Raquel, Graeser, Monika, Wuerstlein, Rachel, Kates, Ronald E., Kreipe, Hans Heinrich, Harbeck, Nadia

Volltext

Abstract GS4-03: Neoadjuvant nab-paclitaxel weekly versus dose-dense paclitaxel followed by dose-dense EC in high risk HR+/HER2- early BC by: Results from the neoadjuvant part of A... von Kuemmel, Sherko, Gluz, Oleg, Nitz, Ulrike, Braun, Michael, Christgen, Matthias, Luedtke-Heckenkamp, Kerstin, von Schumann, Raquel, Darsow, Maren, Forstbauer, Helmut, Potenberg, Jochem, Grischke, Eva-Maria, Aktas, Bahriye, Schumacher, Claudia, Kates, Ronald, Graeser, Monika, Wuerstlein, Rachel, Uleer, Christoph, Hauptmann, Michael, Shak, Steve, Baehner, Rick, Kreipe, Hans, Harbeck, Nadia

Volltext

Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results von Gluz, Oleg, Nitz, Ulrike, Liedtke, Cornelia, Christgen, Matthias, Grischke, Eva-Maria, Forstbauer, Helmut, Braun, Michael, Warm, Mathias, Hackmann, John, Uleer, Christoph, Aktas, Bahriye, Schumacher, Claudia, Bangemann, Nikola, Lindner, Christoph, Kuemmel, Sherko, Clemens, Michael, Potenberg, Jochem, Staib, Peter, Kohls, Andreas, von Schumann, Raquel, Kates, Ronald, Kates, Ronald, Schumacher, Johannes, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Harbeck, Nadia

Volltext

Hormone receptor discordance between local and central pathology with RT-PCR analysis: Results from multicenter Phase III WSG-PlanB trial von Von Schumann, Raquel, Gluz, Oleg, Nitz, Ulrike, Clemens, Michael, Luebbe, Kristina, Aktas, Bahriye, Just, Marianne, Noesselt, Thomas, Henschen, Stephan, Hackmann, John, Lorenz-Salehi, Fatemeh, Freese, Kristin, Svedman, Christer, Kates, Ronald E., Kreipe, Hans Heinrich, Harbeck, Nadia, Liedtke, Cornelia

Volltext

Abstract OT3-2-04: ADAPT - Adjuvant Dynamic marker-Adjusted Personalized Therapy trial optimizing risk assessment and therapy response prediction in early breast cancer von Nitz, Ulrike, Gluz, Oleg, von Schumann, Raquel, Hofmann, Daniel, Kates, Ronald E, Kuemmel, Sherko, Braun, Michael, Schumacher, Claudia, Nuding, Benno, Aktas, Bahriye, Forstbauer, Helmut, Maass, Nicolai, Rezai, Mahdi, Kraemer, Stefan, Warm, Mathias, Wuerstlein, Rachel, Harbeck, Nadia

Volltext

Significance of prospective multicenter decision impact WSG-BCIST Study in postmenopausal ER+ HER2- N0 early breast cancer (EBC) for molecular testing for intrinsic subtype definit... von Wuerstlein, Rachel, Sotlar, Karl, Gluz, Oleg, Hofmann, Daniel, Otremba, Burkhard, Von Schumann, Raquel, Witzel, Isabelle, Schindlbeck, Christian, Janni, Wolfgang, Schem, Chrisitan, Bauerfeind, Ingo, Hasmueller, Stephan, Tesch, Hans, Paulenz, Axel, Morel, Pascale, Cowens, Wayne, Hornberger, John, Kates, Ronald E., Pelz, Enrico, Harbeck, Nadia

Volltext